Tandem Diabetes Care (FRA:TD5A) YoY EBITDA Growth : -237.92% (As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Tandem Diabetes Care YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Tandem Diabetes Care's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was -237.92%.

Tandem Diabetes Care's EBITDA per Share for the three months ended in Mar. 2025 was €-1.62.

Tandem Diabetes Care YoY EBITDA Growth Historical Data

The historical data trend for Tandem Diabetes Care's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tandem Diabetes Care YoY EBITDA Growth Chart

Tandem Diabetes Care Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

35.44

354.35

-333.33

-153.94

63.29

Tandem Diabetes Care Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															72.13	16.63	30.15	116.99	-237.92

Tandem Diabetes Care YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Tandem Diabetes Care's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-1.018	-	-2.773)	/	\| -2.773 \|
=	63.29 %

Tandem Diabetes Care's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(-1.622	-	-0.48)	/	\| -0.48 \|
=	-237.92 %

Tandem Diabetes Care YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Tandem Diabetes Care's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Tandem Diabetes Care Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tandem Diabetes Care Inc (FRA:TD5A) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

TNDM:USA 0M0F:UK

Address

12400 High Bluff Drive, San Diego, CA, USA, 92130

Website

https://www.tandemdiabetes.com

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Tandem Diabetes Care Headlines

No Headlines